References
1. Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P.
Epidemiology and modifiable risk factors for atrial fibrillation.Nat Rev Cardiol. 2023;20(6):404-417.
2. Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE.
Atrial fibrillation in women: epidemiology, pathophysiology,
presentation, and prognosis. Nat Rev Cardiol. 2016;13(6):321-332.
3. Volgman AS, Bairey Merz CN, Benjamin EJ, et al. Sex and
Race/Ethnicity Differences in Atrial Fibrillation. J Am Coll
Cardiol. 2019;74(22):2812-2815.
4. Cho L, Davis M, Elgendy I, et al. Summary of Updated Recommendations
for Primary Prevention of Cardiovascular Disease in Women: JACC
State-of-the-Art Review. J Am Coll Cardiol.2020;75(20):2602-2618.
5. Clayton JA, Gaugh MD. Sex as a Biological Variable in Cardiovascular
Diseases: JACC Focus Seminar 1/7. J Am Coll Cardiol.2022;79(14):1388-1397.
6. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS
Guideline for the Diagnosis and Management of Atrial Fibrillation: A
Report of the American College of Cardiology/American Heart Association
Joint Committee on Clinical Practice Guidelines. Circulation.2023.
7. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs
Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac
Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized
Clinical Trial. JAMA. 2019;321(13):1261-1274.
8. Ko D, Rahman F, Martins MA, et al. Atrial fibrillation in women:
treatment. Nat Rev Cardiol. 2017;14(2):113-124.
9. Cheng X, Hu Q, Gao L, Liu J, Qin S, Zhang D. Sex-related differences
in catheter ablation of atrial fibrillation: a systematic review and
meta-analysis. Europace. 2019;21(10):1509-1518.
10. du Fay de Lavallaz J, Badertscher P, Kobori A, et al. Sex-specific
efficacy and safety of cryoballoon versus radiofrequency ablation for
atrial fibrillation: An individual patient data meta-analysis.Heart Rhythm. 2020;17(8):1232-1240.
11. Yadav R, Milstein J, Blum J, et al. Sex-based differences in safety
and efficacy of catheter ablation for atrial fibrillation. J
Cardiovasc Electrophysiol. 2023;34(8):1640-1647.
12. Kloosterman M, Chua W, Fabritz L, et al. Sex differences in catheter
ablation of atrial fibrillation: results from AXAFA-AFNET 5.Europace. 2020;22(7):1026-1035.
13. Zylla MM, Brachmann J, Lewalter T, et al. Sex-related outcome of
atrial fibrillation ablation: Insights from the German Ablation
Registry. Heart Rhythm. 2016;13(9):1837-1844.
14. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the
diagnosis and management of atrial fibrillation developed in
collaboration with the European Association for Cardio-Thoracic Surgery
(EACTS): The Task Force for the diagnosis and management of atrial
fibrillation of the European Society of Cardiology (ESC) Developed with
the special contribution of the European Heart Rhythm Association (EHRA)
of the ESC. Eur Heart J. 2021;42(5):373-498.
15. Rong B, Han W, Lin M, et al. Thromboembolic Risk of Cessation of
Oral Anticoagulation Post Catheter Ablation in Patients With and Without
Atrial Fibrillation Recurrence. Am J Cardiol. 2020;137:55-62.
16. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the
management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J. 2016;37(38):2893-2962.
17. Kistler PM, Chieng D, Sugumar H, et al. Effect of Catheter Ablation
Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial
Wall Isolation on Atrial Arrhythmia Recurrence in Patients With
Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.JAMA. 2023;329(2):127-135.
18. Chen H, Li C, Han B, et al. Circumferential Pulmonary Vein Isolation
With vs Without Additional Low-Voltage-Area Ablation in Older Patients
With Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial.JAMA Cardiol. 2023;8(8):765-772.
19. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of
pulmonary veins for paroxysmal atrial fibrillation: first results of the
North American Arctic Front (STOP AF) pivotal trial. J Am Coll
Cardiol. 2013;61(16):1713-1723.
20. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy
in Patients with Atrial Fibrillation. N Engl J Med.2020;383(14):1305-1316.
21. Kim SR, Bae S, Lee JY, et al. Gender disparities in prevalence by
diagnostic criteria, treatment and mortality of newly diagnosed acute
myocardial infarction in Korean adults. Sci Rep. 2023;13(1):4120.
22. Buhari H, Fang J, Han L, et al. Stroke risk in women with atrial
fibrillation. Eur Heart J. 2024;45(2):104-113.
23. Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic
disorders. Nat Med. 2019;25(11):1657-1666.
24. Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk
factor for cardiovascular disease and death in women compared with men:
systematic review and meta-analysis of cohort studies. BMJ.2016;532:h7013.
25. Zeitler EP, Kearing S, Coylewright M, et al. Comparative
Effectiveness of Left Atrial Appendage Occlusion Versus Oral
Anticoagulation by Sex. Circulation. 2023;147(7):586-596.
26. Deng H, Shantsila A, Guo P, et al. Sex-related risks of recurrence
of atrial fibrillation after ablation: Insights from the Guangzhou
Atrial Fibrillation Ablation Registry. Arch Cardiovasc Dis.2019;112(3):171-179.
27. Ma Y, Guo L, Liu C, Xu J, Wang Y, Yi F. Sex differences in
paroxysmal atrial fibrillation catheter ablation: A
difference-in-difference propensity score matched analysis. Pacing
Clin Electrophysiol. 2023;46(8):969-977.
28. Jie QQ, Li G, Duan JB, et al. Remodeling of myocardial energy and
metabolic homeostasis in a sheep model of persistent atrial
fibrillation. Biochem Biophys Res Commun. 2019;517(1):8-14.
29. Nattel S, Guasch E, Savelieva I, et al. Early management of atrial
fibrillation to prevent cardiovascular complications. Eur Heart
J. 2014;35(22):1448-1456.
30. Masuda M, Matsuda Y, Uematsu H, et al. Gender Differences in Atrial
Fibrosis and Cardiomyopathy Assessed by Left Atrial Low-Voltage Areas
During Catheter Ablation of Atrial Fibrillation. Am J Cardiol.2023;203:37-44.
31. Van Gelder IC, Ekrami NK, Borof K, et al. Sex Differences in Early
Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial. J
Am Coll Cardiol. 2023;81(8):845-847.
32. Kang DS, Kim D, Jang E, et al. Sex Difference in Effectiveness of
Early Rhythm- over Rate-Control in Patients with Atrial Fibrillation.J Clin Med. 2022;11(17).